Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Eye disorder, Eye irritation, Eye swelling, Facial paralysis
Clinical narrative: Face paralysis; Neck pain; Eye lid palpitations; Problems with the eyes; Swelling  of the eyes; Eyes burn; Face numbness; Headache; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PARALYSIS (Face paralysis) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced FACIAL PARALYSIS (Face paralysis) (seriousness criterion medically significant), NECK PAIN (Neck pain), BLEPHAROSPASM (Eye lid palpitations), EYE DISORDER (Problems with the eyes), EYE SWELLING (Swelling  of the eyes), EYE IRRITATION (Eyes burn), HYPOAESTHESIA (Face numbness), HEADACHE (Headache) and HYPERSENSITIVITY (Allergic reaction). At the time of the report, FACIAL PARALYSIS (Face paralysis), NECK PAIN (Neck pain), BLEPHAROSPASM (Eye lid palpitations), EYE DISORDER (Problems with the eyes), EYE SWELLING (Swelling  of the eyes), EYE IRRITATION (Eyes burn), HYPOAESTHESIA (Face numbness), HEADACHE (Headache) and HYPERSENSITIVITY (Allergic reaction) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.    Patient had a COVID positive test or diagnosis in Jan2021. She had no past medical history or allergies before vaccination and hadn't took any other vaccines within 1 month prior to Moderna. She went to doctor office every week for a month and took Steroid that inflated her like a pig. Patient symptoms sometimes worsened and other times improved. Patient had the same symptoms after booster since 31-jan-2022.  Concomitant medication was not provided Treatment information was not reported.  Company comment: This is a spontaneous case concerning a 41-year-old female patient with no medical history reported, who experienced the expected serious(Medically significant) and AESI  event of facial paralysis, as well as non serious events of neck pain, blepharospasm, eye disorder, eye swelling, eye irritation, hypoaesthesia, headache and hypersensitivity after the first dose of mRNA1273 vaccine. The outcome of the events was not recovered. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-483642 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 41-year-old female patient with no medical history reported, who experienced the expected serious(Medically significant) and AESI  event of facial paralysis, as well as non serious events of neck pain, blepharospasm, eye disorder, eye swelling, eye irritation, hypoaesthesia, headache and hypersensitivity after the first dose of mRNA1273 vaccine. The outcome of the events was not recovered. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.